{"id":"https://openalex.org/W2139396743","doi":"https://doi.org/10.7164/antibiotics.32.36","title":"Biological studies on the degradation products of 3-[(S)-1'-phenylethylamino]propylaminobleomycin: A novel analog (pepleomycin).","display_name":"Biological studies on the degradation products of 3-[(S)-1'-phenylethylamino]propylaminobleomycin: A novel analog (pepleomycin).","publication_year":1979,"publication_date":"1979-01-01","ids":{"openalex":"https://openalex.org/W2139396743","doi":"https://doi.org/10.7164/antibiotics.32.36","mag":"2139396743","pmid":"https://pubmed.ncbi.nlm.nih.gov/83987"},"language":"en","primary_location":{"id":"doi:10.7164/antibiotics.32.36","doi":"https://doi.org/10.7164/antibiotics.32.36","is_oa":true,"landing_page_url":"https://doi.org/10.7164/antibiotics.32.36","pdf_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/32/1/32_1_36/_pdf","source":{"id":"https://openalex.org/S154771817","display_name":"The Journal of Antibiotics","issn_l":"0021-8820","issn":["0021-8820","1881-1469"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Antibiotics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/32/1/32_1_36/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113440552","display_name":"Katsutoshi Takahashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"KATSUTOSHI TAKAHASHI","raw_affiliation_strings":["Research Laboratories, Pharmaceutical Division, Nippon Kayaku Co"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Pharmaceutical Division, Nippon Kayaku Co","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010278449","display_name":"HISAO EKIMOTO","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"HISAO EKIMOTO","raw_affiliation_strings":["Research Laboratories, Pharmaceutical Division, Nippon Kayaku Co"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Pharmaceutical Division, Nippon Kayaku Co","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028142368","display_name":"Shoko Aoyagi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"SHOKO AOYAGI","raw_affiliation_strings":["Research Laboratories, Pharmaceutical Division, Nippon Kayaku Co"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Pharmaceutical Division, Nippon Kayaku Co","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067982655","display_name":"A Koyu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"AKIKO KOYU","raw_affiliation_strings":["Research Laboratories, Pharmaceutical Division, Nippon Kayaku Co"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Pharmaceutical Division, Nippon Kayaku Co","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003533732","display_name":"Hiroshi Kuramochi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"HIROSHI KURAMOCHI","raw_affiliation_strings":["Research Laboratories, Pharmaceutical Division, Nippon Kayaku Co"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Pharmaceutical Division, Nippon Kayaku Co","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"middle","author":{"id":null,"display_name":"OSAMU YOSHIOKA","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"OSAMU YOSHIOKA","raw_affiliation_strings":["Research Laboratories, Pharmaceutical Division, Nippon Kayaku Co"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Pharmaceutical Division, Nippon Kayaku Co","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062680884","display_name":"Akira Matsuda","orcid":"https://orcid.org/0000-0002-0792-3663","observed_orcids":["https://orcid.org/0000-0002-0792-3663"]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"AKIRA MATSUDA","raw_affiliation_strings":["Research Laboratories, Pharmaceutical Division, Nippon Kayaku Co"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Pharmaceutical Division, Nippon Kayaku Co","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110759109","display_name":"Akio Fujii","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"AKIO FUJII","raw_affiliation_strings":["Research Laboratories, Pharmaceutical Division, Nippon Kayaku Co"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Pharmaceutical Division, Nippon Kayaku Co","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103423333","display_name":"HAMAO UMEZAWA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"HAMAO UMEZAWA","raw_affiliation_strings":["Institute of Microbial Chemistry"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Microbial Chemistry","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":null,"fwci":2.5854,"has_fulltext":true,"cited_by_count":49,"citation_normalized_percentile":{"value":0.87972085,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"32","issue":"1","first_page":"36","last_page":"42"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.8895999789237976,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.8895999789237976,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.06809999793767929,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13105","display_name":"Synthesis and pharmacology of benzodiazepine derivatives","score":0.021400000900030136,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/degradation-products","display_name":"degradation products","score":0.8230000138282776},{"id":"https://openalex.org/keywords/enzyme-inactivation","display_name":"enzyme inactivation","score":0.9010000228881836},{"id":"https://openalex.org/keywords/antimicrobial-activity","display_name":"antimicrobial activity","score":0.6899999976158142},{"id":"https://openalex.org/keywords/dna-synthesis-inhibition","display_name":"DNA synthesis inhibition","score":0.9380000233650208},{"id":"https://openalex.org/keywords/dna-cleavage","display_name":"DNA cleavage","score":0.9940000176429749},{"id":"https://openalex.org/keywords/acute-toxicity","display_name":"acute toxicity","score":0.7770000100135803},{"id":"https://openalex.org/keywords/pulmonary-toxicity","display_name":"pulmonary toxicity","score":0.9909999966621399},{"id":"https://openalex.org/keywords/pulmonary-fibrosis","display_name":"pulmonary fibrosis","score":0.9850000143051147}],"concepts":[{"id":"https://openalex.org/C2776232574","wikidata":"https://www.wikidata.org/wiki/Q415571","display_name":"Bleomycin","level":3,"score":0.7460654377937317},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.7235998511314392},{"id":"https://openalex.org/C2777366897","wikidata":"https://www.wikidata.org/wiki/Q847482","display_name":"HeLa","level":3,"score":0.6935923099517822},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6613169312477112},{"id":"https://openalex.org/C2781047374","wikidata":"https://www.wikidata.org/wiki/Q2100012","display_name":"Pulmonary toxicity","level":3,"score":0.5646579265594482},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5464445948600769},{"id":"https://openalex.org/C116263406","wikidata":"https://www.wikidata.org/wiki/Q3299024","display_name":"Acute toxicity","level":3,"score":0.5399245619773865},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.4906517565250397},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4708749055862427},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.4334490895271301},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2102169692516327},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.09328898787498474},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.06103360652923584},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001673","descriptor_name":"Biodegradation, Environmental","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001761","descriptor_name":"Bleomycin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D001761","descriptor_name":"Bleomycin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001761","descriptor_name":"Bleomycin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004247","descriptor_name":"DNA","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D006367","descriptor_name":"HeLa Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008171","descriptor_name":"Lung Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008813","descriptor_name":"Mice, Inbred ICR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009161","descriptor_name":"Mycobacterium","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.7164/antibiotics.32.36","doi":"https://doi.org/10.7164/antibiotics.32.36","is_oa":true,"landing_page_url":"https://doi.org/10.7164/antibiotics.32.36","pdf_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/32/1/32_1_36/_pdf","source":{"id":"https://openalex.org/S154771817","display_name":"The Journal of Antibiotics","issn_l":"0021-8820","issn":["0021-8820","1881-1469"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Antibiotics","raw_type":"journal-article"},{"id":"pmid:83987","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/83987","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antibiotics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.7164/antibiotics.32.36","doi":"https://doi.org/10.7164/antibiotics.32.36","is_oa":true,"landing_page_url":"https://doi.org/10.7164/antibiotics.32.36","pdf_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/32/1/32_1_36/_pdf","source":{"id":"https://openalex.org/S154771817","display_name":"The Journal of Antibiotics","issn_l":"0021-8820","issn":["0021-8820","1881-1469"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Antibiotics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8199999928474426,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2139396743.pdf","grobid_xml":"https://content.openalex.org/works/W2139396743.grobid-xml"},"referenced_works_count":12,"referenced_works":["https://openalex.org/W22230893","https://openalex.org/W112647570","https://openalex.org/W617287817","https://openalex.org/W1966905570","https://openalex.org/W1976213908","https://openalex.org/W1985558501","https://openalex.org/W2027367329","https://openalex.org/W2038124483","https://openalex.org/W2059420054","https://openalex.org/W2115650621","https://openalex.org/W2323753266","https://openalex.org/W2403370211"],"related_works":["https://openalex.org/W1978142921","https://openalex.org/W2409310664","https://openalex.org/W2012016328","https://openalex.org/W2421770491","https://openalex.org/W2036712780","https://openalex.org/W2410627017","https://openalex.org/W2071059650","https://openalex.org/W2475313296","https://openalex.org/W2406490229","https://openalex.org/W2033727035"],"abstract_inverted_index":{"Pepleomycin":[0],"(PEP),":[1],"3-[(S)-1'-phenylethylamino]propylaminobleomycin":[2],"has":[3],"potent":[4],"activity":[5,15,73,115],"and":[6,16,59,79,89,96,121,132,136],"is":[7],"less":[8],"pulmonary":[9,97,140],"toxic":[10],"than":[11,74],"bleomycin":[12],"(BLM).":[13],"Biological":[14],"toxicity":[17,95,98,108],"of":[18,23,32,38,43,46,62,83,139],"the":[19,30,36,41,47,51,55,60,90,111],"following":[20],"degradation":[21,68],"products":[22,69],"PEP":[24,75],"have":[25],"been":[26],"studied":[27],"in":[28,76,86,101,113,128,143],"detail:":[29],"product":[31,37,42,57,61],"carbamoyl":[33],"migration":[34],"(ISO),":[35],"decarbamylation":[39],"(DC),":[40],"ring":[44],"closure":[45],"side":[48],"chain":[49],"on":[50],"pyrimidine":[52],"moiety":[53],"(RC),":[54],"depyruvamide":[56],"(DP)":[58],"an":[63],"enzymatic":[64],"inactivation":[65],"(DA).":[66],"These":[67],"showed":[70,134],"much":[71,105],"lower":[72,106],"vitro:":[77],"antimicrobial":[78],"anti-HeLa":[80],"activities,":[81],"inhibition":[82],"DNA":[84,91],"synthesis":[85],"AH66":[87],"cells":[88],"strand":[92],"cleavage.":[93],"Acute":[94],"were":[99],"tested":[100],"mice.":[102],"Results":[103],"indicated":[104],"acute":[107],"corresponding":[109],"to":[110,118],"decreased":[112],"vitro":[114],"when":[116],"compared":[117],"PEP.":[119,146],"DP":[120],"RC":[122],"did":[123],"not":[124],"cause":[125],"lung":[126],"fibrosis":[127],"mice,":[129],"while":[130],"ISO":[131],"DC":[133],"1/2.6":[135],"1/5.7":[137],"degree":[138],"toxicity,":[141],"respectively,":[142],"comparison":[144],"with":[145]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}